The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
Open accessAbstract
Inflammatory bowel disease is an important risk factor for colorectal cancer. We show that sphingosine-1-phosphate (S1P) produced by upregulation of sphingosine kinase 1 (SphK1) links chronic intestinal inflammation to colitis-associated cancer (CAC) and both are exacerbated by deletion of Sphk2. S1P is essential for production of the multifunctional NF-κB-regulated cytokine IL-6, persistent activation of the transcription factor STAT3, and consequent upregulation of the S1P receptor, S1PR1. The prodrug FTY720 decreased SphK1 and S1PR1 expression and eliminated the NF-κB/IL-6/STAT3 amplification cascade and development of CAC, even in Sphk2(-/-) mice, and may be useful in treating colon cancer in individuals with ulcerative colitis. Thus, the SphK1/S1P/S1PR1 axis is at the nexus between NF-κB and STAT3 and connects chronic inflammation and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“STAT3 is also involved in inflammation-associated carcinogenesis, suppression of the antitumor immune response, and maintenance of cancer stem cells.”
From Critical analysis of the potential for targeting STAT3 in human malignancy (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This process is critically involved in colitis-associated cancer (310).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [310]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2
Yamaguchi, K., Lantowski, A., Dannenberg, A. J., & Subbaramaiah, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503201200 · Cited by 80
RetractedImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Oshima, M., Dinchuk, J. E., Kargman, S., Oshima, H., Hancock, B. C., Kwong, E. C., Trzăskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,363
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Inflammation meets cancer, with NF-κB as the matchmaker
Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,412
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Cited by
Sorted by citations
Sphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,117
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“This process is critically involved in colitis-associated cancer (310).”
BackgroundLipid metabolic reprogramming in cancer cells
Beloribi‐Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,418
Sphingolipid metabolites in inflammatory disease
Maceyka, M. W., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,308
Self-citationSphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Zhang, M., Viennois, É., Prasad, M. A., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,071
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 724
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Cartier, A., & Hla, T. (2019) · Science · doi:10.1126/science.aar5551 · Cited by 647
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Proia, R. L., & Hla, T. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76369 · Cited by 545
An update on the biology of sphingosine 1-phosphate receptors
Blaho, V. A., & Hla, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046300 · Cited by 516
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M. W., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 449
Self-citationmTORC2 Promotes Tumorigenesis via Lipid Synthesis
Guri, Y., Colombi, M., Dazert, E., Hindupur, S. K., Roszik, J., Moes, S., Jenoe, P., Heim, M. H., Riezman, I., Riezman, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.011 · Cited by 418
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. M. (2015) · Nature reviews. Immunology · doi:10.1038/nri3896 · Cited by 410
Lipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 428
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 376
STAT proteins in cancer: orchestration of metabolism
Li, Y., Zhang, C., Martincuks, A., Herrmann, A., & Yu, H. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-022-00537-3 · Cited by 305
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
Newton, J. C., Lima, S., Maceyka, M. W., & Spiegel, S. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.02.025 · Cited by 288
Self-citationThe role of diet in the aetiopathogenesis of inflammatory bowel disease
Khalili, H., Chan, S. S. M., Lochhead, P. J., Ananthakrishnan, A. N., Hart, A. R., & Chan, A. T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0022-9 · Cited by 307
Cancer Inflammation and CytokinesPreprint
Galdiero, M. R., Marone, G., & Mantovani, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028662 · Cited by 274
Munn, L. L. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1370 · Cited by 273
Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats
Zhu, L., Gu, P., & Shen, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.036 · Cited by 253
Nagahashi, M., Yamada, A., Katsuta, E., Aoyagi, T., Huang, W., Terracina, K. P., Hait, N. C., Allegood, J. C., Tsuchida, J., Yuza, K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1423 · Cited by 224
Self-citationTsai, H., & Han, M. H. (2016) · Drugs · doi:10.1007/s40265-016-0603-2 · Cited by 217
Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
Gómez‐Muñoz, A., Presa, N., Gómez-Larrauri, A., Rivera, I.-G., Trueba, M., & Ordoñez, M. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.09.002 · Cited by 220
Hait, N. C., Wise, L. E., Allegood, J. C., O'Brien, M., Avni, D., Reeves, T. M., Knapp, P. E., Lu, J., Luo, C., Miles, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3728 · Cited by 209
Self-citationSTAT3 and epithelial–mesenchymal transitions in carcinomas
Wendt, M. K., Balanis, N. G., Carlin, C. R., & Schiemann, W. P. (2014) · JAK-STAT · doi:10.4161/jkst.28975 · Cited by 206
Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
Medina, C. B., & Ravichandran, K. S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.13 · Cited by 199
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
Pyne, S., Adams, D. R., & Pyne, N. J. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.03.001 · Cited by 198
O’Connor, C. M., Perl, A. L., Léonard, D., Sangodkar, J., & Narla, G. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.008 · Cited by 185
The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer
Hait, N. C., & Maiti, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/4806541 · Cited by 196
Self-citationA basal-like breast cancer-specific role for SRF–IL6 in YAP-induced cancer stemness
Kim, T., Yang, S.-J., Hwang, D., Song, J., Kim, M., Kim, S. K., Kang, K., Ahn, J., Lee, D., Kim, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10186 · Cited by 186
STAT3: a multifaceted oncoprotein
Guanizo, A. C., Fernando, C. D., Garama, D. J., & Gough, D. J. (2018) · Growth Factors · doi:10.1080/08977194.2018.1473393 · Cited by 179
The emerging role of FTY720 (Fingolimod) in cancer treatment
White, C., Alshaker, H. A., Cooper, C., Winkler, M. H., & Pchejetski, D. (2016) · Oncotarget · doi:10.18632/oncotarget.7145 · Cited by 175
Roles, regulation and inhibitors of sphingosine kinase 2
Neubauer, H. A., & Pitson, S. M. (2013) · FEBS Journal · doi:10.1111/febs.12314 · Cited by 171
González, N., Prieto, I., del Puerto‐Nevado, L., Portal‐Núñez, S., Ardura, J. A., Cortón, M., Fernández‐Fernández, B., Aguilera, Ó., Gómez‐Guerrero, C., Mas, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 177
Xiang, M. H., Birkbak, N. J., Vafaizadeh, V., Walker, S. R., Yeh, J., Liu, S., Kroll, Y., Boldin, M., Taganov, K. D., Groner, B., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004497 · Cited by 166
Export of sphingosine-1-phosphate and cancer progression
Takabe, K., & Spiegel, S. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046656 · Cited by 170
Self-citationRoles of sphingosine-1-phosphate signaling in cancer
Wang, P., Yuan, Y., Lin, W., Zhong, H., Xu, K., & Qi, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1014-8 · Cited by 156
Degagné, É., Pandurangan, A. K., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M. D., de Jong, P. J., Fong, L. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74188 · Cited by 157
Selvam, S. P., Palma, R. M. D., Oaks, J. J., Oleinik, N. V., Peterson, Y. K., Stahelin, R. V., Skordalakes, E., Ponnusamy, S., Garrett-Mayer, E. S., Smith, C. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa4998 · Cited by 155
Sukocheva, O. A., Furuya, H., Ng, M. L., Friedemann, M., Menschikowski, M., Tarasov, V. V., Chubarev, V. N., Klochkov, S. G., Неганова, М. Е., Mangoni, A. A., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107464 · Cited by 149
Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis
Hirano, T., Hirayama, D., Wagatsuma, K., Yamakawa, T., Yokoyama, Y., & Nakase, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093062 · Cited by 147
Lipidomics in translational research and the clinical significance of lipid-based biomarkers
Stephenson, D., Hoeferlin, L. A., & Chalfant, C. E. (2017) · Translational research · doi:10.1016/j.trsl.2017.06.006 · Cited by 141
Pyne, N. J., McNaughton, M., Boomkamp, S. D., MacRitchie, N. A., Evangelisti, C., Martelli, A. M., Jiang, H., Ubhi, S., & Pyne, S. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.001 · Cited by 134
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
Verstockt, B., Vetrano, S., Salas, A., Nayeri, S., Duijvestein, M., Casteele, N. V., Danese, S., D’Haens, G., Eckmann, L., Faubion, W. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00574-7 · Cited by 136
Wang, M., Liang, C., Hu, H., Zhou, L., Xu, B., Wang, X., Han, Y., Nie, Y., Jia, S., Liang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep30696 · Cited by 130
Self-citationSphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Weigert, A., Olesch, C., & Brüne, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01706 · Cited by 130
G protein-coupled receptors as promising cancer targets
Liu, Y., An, S., Ward, R. J., Yang, Y., Guo, X., Li, W., & Xu, T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.031 · Cited by 134
Lucafò, M., Curci, D., Franzin, M., Decorti, G., & Stocco, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.772101 · Cited by 130
The role of sphingosine‐1‐phosphate in inflammation and cancer progression
Nagahashi, M., Abe, M., Sakimura, K., Takabe, K., & Wakai, T. (2018) · Cancer Science · doi:10.1111/cas.13802 · Cited by 124
Self-citationEvolving concepts in cancer therapy through targeting sphingolipid metabolism
Truman, J., Garcı́a-Barros, M., Obeid, L. M., & Hannun, Y. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.013 · Cited by 125
Yao, C., Su, L., Shan, J., Zhu, C., Liu, L., Liu, C., Xu, Y., Yang, Z., Bian, X., Shao, J., et al. (2016) · Stem Cells · doi:10.1002/stem.2320 · Cited by 123
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
Nagahashi, M., Yuza, K., Hirose, Y., Nakajima, M., Ramanathan, R., Hait, N. C., Hylemon, P. B., Zhou, H., Takabe, K., & Wakai, T. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r069286 · Cited by 118
Self-citationApigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
Ai, X., Qin, Y., Liu, H.-J., Cui, Z.-H., Li, M., Yang, J., Zhong, W., Liu, Y., Chen, S., Sun, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22145 · Cited by 120
Targeting transcription factors
Yeh, J., Toniolo, P. A., & Frank, D. A. (2013) · Current Opinion in Oncology · doi:10.1097/01.cco.0000432528.88101.1a · Cited by 109
Vascular and immunobiology of the circulatory sphingosine 1-phosphate gradient
Yanagida, K., & Hla, T. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071635 · Cited by 109
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Valdés-Rives, S. A., & González‐Arenas, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/9173090 · Cited by 110
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
Clark, A. R., & Ohlmeyer, M. H. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.016 · Cited by 108
Hait, N. C., Avni, D., Yamada, A., Nagahashi, M., Aoyagi, T., Aoki, H., Dumur, C. I., Zelenko, Z., Gallagher, E. J., LeRoith, D., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.16 · Cited by 105
Self-citationCrystal Structure of Sphingosine Kinase 1 with PF-543
Wang, J., Knapp, S., Pyne, N. J., Pyne, S., & Elkins, J. M. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5004074 · Cited by 101
S1P signaling: new therapies and opportunities
Gonzalez‐Cabrera, P. J., Brown, S. D. M., Studer, S. M., & Rosen, H. (2014) · F1000Prime Reports · doi:10.12703/p6-109 · Cited by 104
Bao, Y., Chen, Z., Guo, Y., Feng, Y., Li, Z., Han, W., Wang, J., Zhao, W., Jiao, Y., Li, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105991 · Cited by 102
Okano, M., Oshi, M., Butash, A. L., Katsuta, E., Tachibana, K., Saito, K., Okayama, H., Peng, X., Yan, L., Kono, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174197 · Cited by 101
Self-citationVenkata, J. K., An, N., Stuart, R. K., Costa, L. J., Cai, H., Coker, W. J., Song, J. H., Gibbs, K., Matson, T., Garrett-Mayer, E. S., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559385 · Cited by 101
High levels of sphingolipids in human breast cancer
Nagahashi, M., Tsuchida, J., Moro, K., Hasegawa, M. L., Tatsuda, K., Woelfel, I. A., Takabe, K., & Wakai, T. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.05.022 · Cited by 101
Self-citationRutherford, C., Childs, S., Ohotski, J., McGlynn, L. M., Riddick, M., Macfarlane, S. R., Tasker, D., Pyne, S., Pyne, N. J., Edwards, J., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.455 · Cited by 100
S1PR1 Is Crucial for Accumulation of Regulatory T Cells in Tumors via STAT3
Priceman, S. J., Shen, S., Wang, L., Deng, J., Yue, C., Kujawski, M., & Yu, H. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.016 · Cited by 99
Garcı́a-Barros, M., Coant, N., Truman, J., Snider, A. J., & Hannun, Y. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.007 · Cited by 98
Sphingosine-1-Phosphate Transporters as Targets for Cancer Therapy
Nagahashi, M., Takabe, K., Terracina, K. P., Soma, D., Hirose, Y., Kobayashi, T., Matsuda, Y., & Wakai, T. (2014) · BioMed Research International · doi:10.1155/2014/651727 · Cited by 97
Self-citationAcid ceramidase is upregulated in AML and represents a novel therapeutic target
Tan, S., Liu, X., Fox, T. E., Barth, B. M., Sharma, A. K., Turner, S., Awwad, A., Dewey, A., Doi, K., Spitzer, B. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13079 · Cited by 97
Morris, G., Bortolasci, C. C., Puri, B. K., Marx, W., O'Neil, A. E., Athan, E., Walder, K. R., Berk, M., OLIVE, L. S., Carvalho, A. F., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155593 · Cited by 101
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97
Danese, S., Furfaro, F., & Vetrano, S. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx107 · Cited by 98
Recent advances in the development of sphingosine kinase inhibitors
Pitman, M. R., Costabile, M., & Pitson, S. M. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.007 · Cited by 93
Zhang, H., Xu, Z.-S., Lin, H. I., Li, M., Xia, T., Cui, K., Wang, S., Li, Y., Shu, H., & Wang, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-05796-z · Cited by 90
Zhang, F., Xia, Y., Yan, W., Zhang, H., Zhou, F., Zhao, S., Wang, W., Zhu, D., Xin, C., Lee, Y., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2015 · Cited by 91
Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity
Ansari, S., Gantuya, B., Tuan, V. P., & Yamaoka, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082424 · Cited by 90
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
Boldyreva, L. V., Morozova, M. V., Medvedeva, S. S., & Kozhevnikova, E. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111682 · Cited by 94
Deng, Z., Mu, J., Tseng, M. T., Wattenberg, B. W., Zhuang, X., Egilmez, N. K., Wang, Q., Zhang, L., Norris, J. S., Guo, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7956 · Cited by 92
Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention
Li, W., Zhao, T., Wu, D., Li, J., Wang, M., Sun, Y., & Hou, S. (2022) · Current Oncology · doi:10.3390/curroncol29090479 · Cited by 95
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness
Moro, K., Kawaguchi, T., Tsuchida, J., Gabriel, E. M., Qi, Q., Yan, L., Wakai, T., Takabe, K., & Nagahashi, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24903 · Cited by 88
Self-citationOshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Nagahashi, M., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186708 · Cited by 89
Self-citationvon Manstein, V., Yang, C., Richter, D. E., Delis, N., Vafaizadeh, V., & Groner, B. (2014) · Current Signal Transduction Therapy · doi:10.2174/1574362409666140206221931 · Cited by 88
Mechanisms of sphingosine 1-phosphate receptor signalling in cancer
Patmanathan, S. N., Wang, W., Yap, L. F., Herr, D. R., & Paterson, I. C. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.03.002 · Cited by 89
Lankadasari, M. B., Aparna, J. S., Mohammed, S., James, S., Aoki, K., Binu, V. S. N., Nair, S., & Harikumar, K. B. (2018) · Theranostics · doi:10.7150/thno.25308 · Cited by 88
Self-citationMechanisms of Ceramide-Dependent Cancer Cell Death
Nganga, R., Oleinik, N. V., & Öğretmen, B. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.007 · Cited by 92
Wang, X., Zhang, D., Gu, T., Ding, X., Fan, C., Zhu, Q., Shi, Y., Hong, Y., & Kong, L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.005 · Cited by 87
Moro, K., Nagahashi, M., Ramanathan, R., Takabe, K., & Wakai, T. (2016) · World Journal of Clinical Cases · doi:10.12998/wjcc.v4.i7.155 · Cited by 92
Self-citationSphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells
Pyne, N. J., & Pyne, S. (2017) · Molecules · doi:10.3390/molecules22030344 · Cited by 85
Donoviel, M. S., Hait, N. C., Ramachandran, S., Maceyka, M. W., Takabe, K., Milstien, S., Oravecz, T., & Spiegel, S. (2015) · The FASEB Journal · doi:10.1096/fj.15-274936 · Cited by 84
Self-citationSphingosine-1-phosphate in chronic intestinal inflammation and cancer
Nagahashi, M., Hait, N. C., Maceyka, M. W., Avni, D., Takabe, K., Milstien, S., & Spiegel, S. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.10.001 · Cited by 83
Self-citationBohonowych, J. E. S., Hance, M. W., Nolan, K., DeFee, M. R., Parsons, C., & Isaacs, J. (2013) · The Prostate · doi:10.1002/pros.22761 · Cited by 84
Olesch, C., Ringel, C., Brüne, B., & Weigert, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/6059203 · Cited by 85
Regulation of PP2A by Sphingolipid Metabolism and Signaling
Oaks, J. J., & Öğretmen, B. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00388 · Cited by 84
Shao, Y., Nanayakkara, G., Cheng, J., Cueto, R., Yang, W. Y., Park, J., Wang, H., & Yang, X. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7069 · Cited by 79
The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy
Sheridan, M., & Öğretmen, B. (2021) · Cancers · doi:10.3390/cancers13102475 · Cited by 82
Metadata
- Authors
- Liang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., Takabe, K., Kordula, T., Milstien, S., & Spiegel, S.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Spiegel, Sarah
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 23
- Issue
- 1
- Pages
- 107-120
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3578577
- OpenAlex
- W2145876349
- Cited by
- 563
- References
- 62
- Citations by year
- 2026: 21 · 2025: 29 · 2024: 35 · 2023: 20 · 2022: 37 · 2021: 45 · 2020: 51 · 2019: 42 · 2018: 44 · 2017: 57 · 2016: 59 · 2015: 48 · 2014: 48 · 2013: 25
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Susan G. Komen
- National Institutes of Health (5k12hd055881-05)
- Japan Society for the Promotion of Science
- National Heart, Lung, and Blood Institute (T32HL094290)
- National Cancer Institute (P30CA16059, R01CA160688, R01CA-61774, R01CA061774, P30CA016059)
- National Institute of General Medical Sciences (R37GM043880)
- National Institute of Allergy and Infectious Diseases (U19AI077435)
- National Institute of Neurological Disorders and Stroke (P30NS047463)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD055881)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- sphingosine-1-phosphate, sphingosine kinase 1, sphingosine kinase 2, S1PR1, STAT3 activation, NF-κB, interleukin-6, colitis-associated colorectal cancer, inflammatory bowel disease, ulcerative colitis, fingolimod, chronic intestinal inflammation, colorectal cancer
- MeSH terms
- Fingolimod Hydrochloride, Sphingosine Kinase, Animals, Cell Transformation, Neoplastic, Colitis, Colon, Lysophospholipids, Propylene Glycols, Sphingosine, Interleukin-6, Gene Expression Regulation, Neoplastic, NF-kappa B, Gene Deletion, Phosphotransferases (Alcohol Group Acceptor), STAT3 Transcription Factor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
